|
Gene mutations of SWI/SNF complex and molecular profile in colorectal cancer. |
|
|
No Relationships to Disclose |
|
|
Employment - Caris Life Sciences |
|
|
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Merck; Merck KGaA |
|
|
Honoraria - Amgen; ASLAN Pharmaceuticals; Bayer; Biologics; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Lexi Pharma; Merck; Novartis; Rafael Pharmaceuticals; Sanofi |
Consulting or Advisory Role - Celgene; Halozyme; Ipsen; Merck; Merrimack; novartis; Rafael Pharmaceuticals |
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Celgene; Ipsen; Merck |
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); TYME (Inst) |
Other Relationship - Halozyme |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Amgen; Bayer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Caris Life Sciences |
|
|
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Centers of Excellence; Eisai; Genentech/Roche; Ipsen; Lilly; Taiho Pharmaceutical |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Genentech/Roche; Ipsen |
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst) |
|
|
Consulting or Advisory Role - Caris Life Sciences; ImaginAb; TransTarget |
Speakers' Bureau - GE Healthcare |
Research Funding - Bayer; Boehringer Ingelheim; Caris Life Sciences; Daiichi Sankyo; Eisai; Exelixis; H3 Biomedicine; Halozyme; ImaginAb; Incyte; Inovio Pharmaceuticals; Lexicon; LSK BioPharma; Plexxikon; Taiho Pharmaceutical; Torque; Xencor |
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget |
|
|
Employment - Caris Life Sciences |
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical |
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche; Taiho Pharmaceutical |
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst) |
|
|
Honoraria - Lilly; Ono Pharmaceutical; Taiho Pharmaceutical |
Research Funding - Chugai Pharma (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche |